ATOMIC Ears: A Phase IIB randomised controlled trial to assess safety, tolerability and acceptability of a 5-day Dornase alfa treatment as an adjunct therapy to ventilation tube insertion for otitis media in children
Latest Information Update: 18 Apr 2022
At a glance
- Drugs Dornase alfa (Primary)
- Indications Otitis media
- Focus Adverse reactions
- Acronyms ATOMIC Ears
- 16 Nov 2021 New trial record